Position in ADMA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$24,900
-$2,130 QoQ
Shares Held
2,975
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#259
of 323 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VISION FINANCIAL MARKETS LLC holds $182,940 across 7 Biotechnology names. ADMA ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLS |
SELLAS Life Sciences Group, Inc.
|
9,800 | $144,648 | |
| 2 | ADMA |
Adma Biologics, Inc.
This page
|
2,975 | $24,900 | |
| 3 | MRNA |
Moderna, Inc.
|
100 | $7,003 | |
| 4 | TWST |
Twist Bioscience Corp
|
50 | $5,144 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
20 | $1,090 | |
| 6 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
14 | $131 | |
| 7 | MTNB |
Matinas BioPharma Holdings, Inc.
|
40 | $24 |
All Filings in ADMA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,900 | 2,975 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $27,030 | 3,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $54,720 | 3,000 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $43,980 | 3,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $54,630 | 3,000 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $59,520 | 3,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $51,450 | 3,000 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||